| 主要会计数据 | 本报告期 | 上年同期 | | --- | --- | --- | | | (1-6月) | | | 营业收入 | 3,359,091,481.62 | 3, 166, 884, 956. 9( | | 利润总额 | 419.058, 407. 90 | 217, 343, 169. 06 | | 归属于上市公司股东的净利润 | 338, 476, 158. 53 | 170, 793, 101. 52 | | 归属于上市公司股东的扣除非经常 性损益的净利润 | 276, 982, 344. 36 | 159, 927, 359. 95 | | 经营活动产生的现金流量净额 | 144. 468, 417. 86 | 94. 363. 867. 75 | | | 本报告期末 | 上年度末 | | 归属于上市公司股东的净资产 | 4.011.067. 405. 39 | 3, 718, 441, 923. 96 | 以8月25日收盘价计算，江山股份目前市盈率（TTM）约为26.6倍，市净率（LF）约2.6倍，市销率（TTM）约1.85倍。 市盈率(TTM)历史分位(%) 100 ହି 90 ...

| 市场数据：2025 年 8 月 | 25 日 | | | --- | --- | --- | | 收盘价（元）： | | 71.25 | | 年内最高/最低（元）： | | 71.77/46.12 | | 流通A股/总股本（亿）： | | 4.04/4.05 | | 流通 A 股市值（亿）： | | 287.84 | | 总市值（亿）： | | 288.85 | | 年 基础数据：2025 | 月 6 | 日 30 | | | --- | --- | --- | --- | | 基本每股收益(元)： | | | 2.00 | | 摊薄每股收益(元)： | | | 2.00 | | 每股净资产(元)： | | | 27.45 | | 净资产收益率(%)： | | | 7.24 | 公司近一年市场表现 分析师： 李旋坤 执业登记编码：S0760523110004 邮箱：lixuankun@sxzq.com 王金源 执业登记编码：S0760525080001 邮箱：wangjinyuan@sxzq.com 农药 扬农化工（600486.SH） 买入-B(维持) 投资建议 预计公司 2025-2027 年归母净利 ...

上 市 公 司 基础化工 2025 年 08 月 25 日 润丰股份 (301035) —— 运营质量持续改善，Model C 业务渐入佳境 报告原因：有业绩公布需要点评 买入（维持） | 市场数据： | 2025 年 08 月 22 日 | | --- | --- | | 收盘价（元） | 72.41 | | 一年内最高/最低（元） | 78.47/35.70 | | 市净率 | 2.9 | | 股息率%（分红/股价） | 0.81 | | 流通 A 股市值（百万元） | 20,300 | | 上证指数/深证成指 | 3,825.76/12,166.06 | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 06 月 30 日 | | --- | --- | | 每股净资产（元） | 25.22 | | 资产负债率% | 54.30 | | 总股本/流通 A 股（百万） | 281/280 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 08-22 09-22 10-22 11-22 12-22 01-22 02-22 03-22 04- ...

Core Viewpoint - The company reported a revenue of 6.23 billion yuan for the first half of 2025, with a year-on-year growth of 9.4%, and a net profit attributable to shareholders of 810 million yuan, reflecting a year-on-year increase of 5.6% [1] Group 1: Financial Performance - In Q2 2025, the company achieved a revenue of 2.99 billion yuan, representing a year-on-year increase of 18.6%, and a net profit of 370 million yuan, up 11.1% year-on-year [1] - For H1 2025, the company's raw materials and formulations revenue were 3.66 billion yuan and 1.17 billion yuan, showing a year-on-year increase of 10.0% and a decrease of 2.8% respectively [2] - The gross margin for H1 2025 was 23.6%, down 0.6 percentage points year-on-year, while the net margin was 12.9%, down 0.5 percentage points year-on-year [2] Group 2: Market Conditions - The agricultural chemical industry is expected to recover as global pesticide distribution channel inventories have been reduced to reasonable levels, following previous price declines due to new capacity and inventory destocking by major players [3] - As of August 15, 2025, the price indices for herbicides and insecticides have shown increases of 0.33% and 2.81% year-on-year, respectively, indicating a stabilization and potential recovery in prices [3] Group 3: Growth Prospects - The company is progressing steadily with its ongoing projects, including the Liaoning Youchuang Phase I project, which has achieved a revenue of 550 million yuan in H1 2025 [4] - The company anticipates continued performance improvement as new products from ongoing projects are gradually released into the market, alongside the recovery of the agricultural chemical industry [4] Group 4: Profit Forecast and Valuation - The company forecasts net profits attributable to shareholders for 2025-2027 to be 1.41 billion, 1.72 billion, and 2.02 billion yuan, with year-on-year growth rates of 17.04%, 22.17%, and 17.26% respectively [5] - The current price-to-earnings ratios are projected to be 20.1, 16.5, and 14.1 times for the respective years, indicating a favorable valuation as production projects come online and product prices stabilize [5]

风险提示：股市有风险，投资需谨慎。 农心科技主营业务为农药制剂产品的研发、生产和销售。公司产品涵盖杀虫剂、杀菌剂、除草剂等系列 产品，广泛应用于农业生产领域。公司注册地位于陕西省，属于农药兽药行业。 公司在互动平台披露，截至2025年8月20日，公司股东人数为9701户。这一数据较此前披露的股东人数 有所变化。 农心科技股价报21.41元，较前一交易日下跌0.59元，跌幅2.68%。当日开盘价为22.00元，最高触及 22.00元，最低下探至21.19元，成交量为18093手，成交金额达0.39亿元。 ...

Group 1 - The core viewpoint of the articles highlights the recent performance and financial metrics of Jiangshan Co., Ltd, including stock price movements and trading volumes [1][2] - As of August 22, Jiangshan's stock price decreased by 2.01% to 23.86 CNY per share, with a total market capitalization of 10.275 billion CNY [1] - Year-to-date, Jiangshan's stock price has increased by 66.27%, with a 6.23% rise over the last five trading days and a 23.63% increase over the last 60 days [1] Group 2 - As of March 31, Jiangshan had 21,800 shareholders, an increase of 4.61% from the previous period, with an average of 19,717 circulating shares per shareholder, down by 4.40% [2] - For the first quarter of 2025, Jiangshan reported a revenue of 1.746 billion CNY, reflecting a year-on-year growth of 10.15% [2] - Since its A-share listing, Jiangshan has distributed a total of 2.499 billion CNY in dividends, with 1.106 billion CNY distributed over the past three years [2] Group 3 - Jiangshan Co., Ltd specializes in agricultural chemicals, primarily focusing on herbicides and insecticides, and is categorized under the basic chemical industry [1] - The company is involved in several concept sectors, including ecological agriculture, glyphosate, rural revitalization, biopesticides, and phosphorus chemicals [1]

Summary of Key Points Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. held a half-year performance briefing on August 19, 2025, to discuss its financial results and future strategies, highlighting significant revenue growth and ongoing projects in the agricultural chemicals and new energy sectors [1][2]. Group 1: Financial Performance - For the first half of 2025, the company achieved a revenue of 619 million yuan, representing an increase of 18.74% year-on-year [4]. - The net profit attributable to shareholders was 30 million yuan, showing a substantial rise of 235.40% compared to the previous year, driven by a recovery in the pesticide industry and successful market expansion efforts [4]. Group 2: Product and Market Development - The company reported that its pesticide categories (insecticides, herbicides, and fungicides) have been performing well, with specific revenue contributions detailed in prior disclosures [3]. - The company is actively pursuing a "second growth curve" by exploring projects in new energy electrolyte and fine chemical new materials, alongside its established pesticide business [5][6]. Group 3: Project Updates - The Hubei project commenced trial production on January 8, 2025, with products already being sold in batches, indicating progress in operational plans [5]. - The Hubei project is expected to produce various chemical products, including ortho-chlorotoluene and its derivatives, which are essential for pharmaceuticals and agricultural chemicals [9][10]. Group 4: Strategic Direction - The company aims to enhance its pesticide, new energy electronic chemicals, and fine chemical new materials sectors, focusing on quality improvement, market demand alignment, and safety management [6]. - The company anticipates that the pesticide industry will continue to grow due to increasing global food demand, emphasizing the importance of innovation and international market expansion [7]. Group 5: Research and Development - Research and development investments are focused on innovations in pesticide production processes, new product formulations, and the development of new electrolyte products for sodium-ion and lithium-ion batteries [11].

Core Viewpoint - Shenzhen Noposion Agrochemical Co., Ltd. reported a revenue increase of 8.20% year-on-year for the first half of 2025, driven by growth in its specialty fresh consumption and pesticide formulation businesses [1][2]. Company Overview and Key Financial Indicators - The company did not distribute cash dividends or issue bonus shares for the reporting period [1]. - Total revenue for the first half of 2025 was approximately CNY 3.68 billion, compared to CNY 3.40 billion in the same period last year [2]. - Net profit attributable to shareholders increased by 17.35% to approximately CNY 648 million [2]. - The company’s total assets grew by 9.33% to approximately CNY 12.28 billion [2]. Business Operations - The company focuses on the specialty fresh consumption sector, particularly blueberries, and aims to establish a comprehensive supply chain for this product [3][4]. - Noposion has been enhancing its agricultural technology services and distribution channels, particularly in the pesticide formulation sector, to strengthen its market position [5][6]. Financial Performance Analysis - Revenue from the pesticide formulation business was approximately CNY 1.49 billion, representing a growth of 8.94% [8]. - The specialty fresh consumption business generated approximately CNY 1.82 billion, with an increase of 18.62% year-on-year [8]. - The company’s operating costs rose by 6.29% to approximately CNY 2.29 billion, reflecting the increase in revenue [8]. Competitive Advantages - The company has established a strong distribution network and technical service team, enhancing its ability to serve large agricultural producers [5]. - Noposion's focus on a single crop strategy allows for a more integrated approach to product and service offerings, which has been well-received by farmers [4][5]. - The company has invested in modern agricultural practices, including automated and technology-driven farming methods, which create high barriers to entry in the industry [4]. Cash Flow and Investment Activities - The net cash flow from operating activities was approximately CNY 254 million, a decrease of 20.19% compared to the previous year [8]. - The net cash flow from investment activities improved significantly, with a reduction in outflows by 65.03% [8]. - The net cash flow from financing activities decreased by 83.38%, indicating reduced borrowing [8].

Core Viewpoint - The company reported a significant improvement in its financial performance for the first half of 2025, driven by a recovery in the pesticide industry and effective cost management [4][5]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.083 billion yuan, a year-on-year increase of 7.3% [4]. - The net profit attributable to shareholders reached 42 million yuan, marking a substantial year-on-year increase of 117.8% [4]. - For the second quarter of 2025, the company reported operating revenue of 1.163 billion yuan, up 7.5% year-on-year and 26.4% quarter-on-quarter [4]. - The net profit attributable to shareholders for Q2 2025 was 26 million yuan, reflecting a year-on-year increase of 122.3% and a quarter-on-quarter increase of 53.3% [4]. Market Demand and Product Performance - The pesticide market demand has rebounded, with the company’s herbicides, insecticides, fungicides, and regulators generating revenues of 1.06 billion, 790 million, 170 million, and 80 million yuan respectively, with year-on-year changes of +14.8%, +0.5%, -3.3%, and +40.1% [5]. - The gross profit margins for these products were 11.1%, 15.7%, 13.9%, and 26.9%, with year-on-year changes of -4.1, +8.6, -0.1, and +17.3 percentage points respectively [5]. - The company’s export sales reached 1.087 billion yuan, a year-on-year increase of 19.61%, supported by international market demand recovery and proactive customer engagement [5]. Production Capacity and Market Coverage - As of the end of 2024, the company had a raw material production capacity of 43,910 tons per year and a formulation capacity of 20,000 tons per year, with an additional 5,500 tons per year of raw material capacity under trial or construction [6]. - The company has established a comprehensive sales network across over 30 provinces in China and holds registrations for over 40 types of raw materials and 150 types of formulations, ensuring adaptability to various agricultural needs [6]. - The company has self-operated import and export rights and has formed stable partnerships with several multinational companies, enhancing its competitive edge in international markets [6].

Investment Rating - The report maintains an "Accumulate" rating for the company [6]. Core Views - The pesticide industry is experiencing a recovery in market demand, leading to a significant improvement in the company's net profit attributable to shareholders in the first half of 2025 [1][2]. - The company achieved a revenue of 2.083 billion yuan in 25H1, a year-on-year increase of 7.3%, and a net profit of 42 million yuan, up 117.8% year-on-year [1]. - The company is focusing on optimizing its product structure and accelerating overseas market registration to capture orders, resulting in export sales of 1.087 billion yuan, a year-on-year increase of 19.61% [2]. Summary by Sections Financial Performance - In 25H1, the company reported revenues from herbicides, insecticides, fungicides, and regulators of 1.06 billion, 790 million, 170 million, and 80 million yuan respectively, with year-on-year changes of +14.8%, +0.5%, -3.3%, and +40.1% [2]. - The gross margins for these products were 11.1%, 15.7%, 13.9%, and 26.9%, with year-on-year changes of -4.1, +8.6, -0.1, and +17.3 percentage points [2]. Capacity and Production - As of the end of 2024, the company has a raw material production capacity of 43,910 tons per year and a formulation capacity of 20,000 tons per year, with an additional 5,500 tons per year of raw material capacity under trial operation or construction [3]. - The company is advancing its production debugging and safety production for the relocation project along the Yangtze River, which is expected to support its performance in 2025 [2]. Profit Forecast and Valuation - The report adjusts the profit forecast for 2025-2026 downwards, with the expected net profits for 2025, 2026, and 2027 being 74 million, 128 million, and 181 million yuan respectively [4]. - The company is expected to benefit from the release of its construction capacity, which will support sustainable and healthy development [4].